(Q39691682)

14 September 2017

1 reference

title

The therapeutic use of azathioprine in renal transplantation (English)

1 reference

14 September 2017

1 reference

Chan GL

1

1 reference

14 September 2017

Canafax DM

series ordinal

2

1 reference

14 September 2017

Johnson CA

series ordinal

3

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 January 1987

1 reference

14 September 2017

1 reference

14 September 2017

7

1 reference

14 September 2017

5

1 reference

14 September 2017

165-177

1 reference

The Effects of Azathioprine and 6 mp on Immunity

14 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Effects of azathioprine on the human mixed lymphocyte reaction (MLR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Strength of the human mixed lymphocyte reaction (MLR) and its suppression by azathioprine or 6-mercaptopurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Azathioprine suppresses the mixed lymphocyte reaction of patients with Lesch-Nyhan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Assay of thioinosinic acid, an active metabolite of azathioprine, in human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Assay of azathioprine, 6-mercaptopurine and a novel thiopurine metabolite in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

21 January 2018

Drug metabolite kinetics

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Studies on the mechanism of formation of 5-mercapto-1-methyl-4-nitroimidazole, a metabolite of the immunosuppressive drug azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Conversion of azathioprine into mercaptopurine and mercaptoimidazole derivatives in vitro and during immunosuppressive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

The pharmacology and metabolism of the thiopurine drugs 6-mercaptopurine and azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

The effect of azathioprine on gammaglobulin synthesis in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Effects of azathioprine in a disorder of uric acid metabolism and cerebral function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

The effects of azathioprine (imuran) on purine synthesis in clinical disorders of purine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Immunological observations on patients with Lesch-Nyhan syndrome, and on the role of de-novo purine synthesis in lymphocyte transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

INHIBITION OF INOSINE 5'-PHOSPHATE DEHYDROGENASE FROM EHRLICH ASCITES-TUMOUR CELLS BY 6-THIONINOSINE 5'-PHOSPHATE

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Inhibition of adenylosuccinate synthetase and adenylosuccinate lyase from Ehrlich ascites-tumour cells by 6-thioinosine 5′-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Inactivation of guanosine 5'-phosphate reductase by 6-chloro-, 6-mercapto-, and 2-amino-6-mercapto-9-beta-D-ribofuranosylpurine 5'-phosphates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Azathioprine and 6-mercaptopurine (6-MP) suppress the human mixed lymphocyte reaction (MLR) by different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Prolonged survival of human-kidney homografts by immunosuppressive drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

One hundred kidney transplants in the Belfast city hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Beneficial effects of cyclosporine compared with azathioprine in cadaveric renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Comparison of kidney transplant survival between patients treated with cyclosporine and those treated with azathioprine and antithymocyte globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Clinical experience with cyclosporine and azathioprine at Brigham and Women's Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Cyclosporine-steroid combination therapy in 84 cadaveric renal transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Severe megaloblastic anaemia associated with abnormal azathioprine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Orthotopic autotransplantation and allotransplantation of the liver: functional and structural patterns in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Peliosis hepatis in recipients of renal transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Cyclophosphamide and human organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Hemorrhagic pancreatitis. A fatal complication of renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Death after transplantation; an analysis of sixty cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Azathioprine and urinary bladder tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Adenocarcinoma of the lung during azathioprine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Development of malignant cerebral lymphoma in a patient with systemic lupus erythematosus treated with immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

De-novo brain tumours in renal-transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Investigation into the mutagenic activity of azathioprine (Imuran®) in different test systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Polyneuritis associated with azathioprine sensitivity reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Azathioprine-induced shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Two chromosome aberrations in the child of a woman with systemic lupus erythematosus treated with azathioprine and prednisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Interstitial pneumonitis secondary to azathioprine in a renal transplant patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Formication and azathioprine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Hypersensitivity to azathioprine in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Childhood leukaemia: a relationship between intracellular 6-mercaptopurine metabolites and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Azathioprine metabolism in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

6-Mercaptopurine: apparent lack of relation between prescribed dose and biological effect in children with leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

In vitro Evaluation of Immunosuppressive Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

Sulphydryl Groups on the Surface of Intact Ehrlich Ascites Tumour Cells, Human Blood Platelets and Lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04046.X

10.1002/J.1875-9114.1987.TB04046.X

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference